Evidence map›Paper›PMID 40302549›Full record

ArticleRecent advances in anti-infective drug discovery2025

An

Heba Z Alagha, Murat Gülsoy

Abstract read
PubMed Publisher
In one paragraph

Article in Recent advances in anti-infective drug discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Heba Z AlaghaInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.ORCID 0000-0001-7564-1054
Murat GülsoyInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.

Funding

Boğaziçi University 15121
6 · The paper itself

Abstract

backgroundThe aim of this study was to investigate the antimicrobial photodynamic, sonodynamic, and combined photodynamic and sonodynamic potentials of IR780 iodide loaded mesoporous silica nanoparticles against gram-negative

methodsIR780 iodide loaded mesoporous silica nanoparticles were synthesized, and their antimicrobial photodynamic and sonodynamic potentials against one

resultsThe results revealed that for

conclusionThe results of this study demonstrated that IR780 iodide-loaded mesoporous silica nanoparticles have the potential to be utilized as photo/sono therapeutic agents for the inactivation of drug-resistant bacteria.

Indexed as

Anti-Bacterial AgentsIndolesNanoparticlesPhotochemotherapyPhotosensitizing AgentsPseudomonas aeruginosaSilicon DioxideUltrasonic TherapyCombined Modality TherapyDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsPorosityUltrasonic Waves2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindoliumAnti-Bacterial AgentsIndolesPhotosensitizing AgentsSilicon Dioxideantimicrobial resistanceIR780 iodideMDR Pseudomonas aeruginosamesoporous silica nanoparticlesphotodynamic therapyPseudomonas aeruginosasonodynamic therapy.

Identifiers

PMID40302549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.